CARDIOPLEXOL 4/0.746/4.5/0.3 g sol 1 pce
7680680150016
CH-68015
B05XA16
02.99.0.
Active substances:
1 / 2
google
Details
- GTIN
- 7680680150016
- Pharmacode
- -
- Product number
- 6801501
- CPT
- -
- Packaging group
- 1
- Unit
- Set
- Composition
- I) Lösung A / 95 mL: magnesii sulfas heptahydricus 4 g, kalii chloridum 0.746 g, xylitolum 4.5 g, acidum citricum monohydricum, natrii hydroxidum corresp. natrium 326 - 345 mg, aqua ad iniectabile q.s. ad solutionem pro 95 ml. II) Lösung B / 5 mL: procaini hydrochloridum 0.3 g, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml, Corresp. procaini hydrochloridum 1.1 mmol. I) et II) corresp. Mischung aus Lösung A + Lösung B: magnesii sulfas heptahydricus 4 g, kalii chloridum 0.746 g, xylitolum 4.5 g, procaini hydrochloridum 0.3 g, acidum citricum monohydricum, natrii hydroxidum corresp. natrium 345 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 100 ml, Corresp. procaini hydrochloridum 1.1 mmol, magnesii sulfas heptahydricus 16.2 mmol, kalii chloridum 10 mmol, xylitolum 29.6 mmol.
Articles (1)
Cardioplexol, Kardioplege Lösung
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
procaini hydrochloridum
|
0.3 G | Substance | Wirkstoff (Principe actif) |
|
magnesii sulfas heptahydricus
|
4.0 G | Substance | Wirkstoff (Principe actif) |
|
magnesii sulfas heptahydricus
|
4.0 G | Substance | Wirkstoff (Principe actif) |
|
kalii chloridum
|
0.746 G | Substance | Wirkstoff (Principe actif) |
|
kalii chloridum
|
0.746 G | Substance | Wirkstoff (Principe actif) |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
xylitolum
|
4.5 G | Substance | Wirkstoff (Principe actif) |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
xylitolum
|
4.5 G | Substance | Wirkstoff (Principe actif) |
|
procaini hydrochloridum
|
0.3 G | Substance | Wirkstoff (Principe actif) |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
|
procaini hydrochloridum
|
1.1 MMOL | Substance | WIZUS |
|
natrium
|
345.0 MG | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
procaini hydrochloridum
|
1.1 MMOL | Substance | Wirkstoff (Principe actif) |
|
magnesii sulfas heptahydricus
|
16.2 MMOL | Substance | Wirkstoff (Principe actif) |
|
kalii chloridum
|
10.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
xylitolum
|
29.6 MMOL | Substance | Wirkstoff (Principe actif) |
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 68015
- Drug name
- Cardioplexol, Kardioplege Lösung
- Galenic form
- LSKP
- ATC Code
- B05XA16
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 31/08/2023
- Authorization expiration date
- 30/08/2028
- IT number
- 02.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CARDIOPLEXOL 4/0.746/4.5/0.3 g sol 1 pce
- Description (DE)
- CARDIOPLEXOL 4/0.746/4.5/0.3 g Lös. 1 Stk
- Market launch
- 31/08/2023
- Narcotic (BTM)
- No